Afya (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon Sells 800 Shares of Stock

Afya Limited (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon sold 800 shares of the stock in a transaction on Thursday, March 26th. The stock was sold at an average price of $15.21, for a total value of $12,168.00. Following the completion of the transaction, the chief executive officer directly owned 153,748 shares in the company, valued at $2,338,507.08. This trade represents a 0.52% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Virgilio Deloy Capobian Gibbon also recently made the following trade(s):

• On Wednesday, March 25th, Virgilio Deloy Capobian Gibbon sold 3,900 shares of Afya stock. The shares were sold at an average price of $15.18, for a total transaction of $59,202.00.

Afya Stock Down 1.3%

Shares of Afya stock opened at $14.75 on Friday. Afya Limited has a twelve month low of $13.00 and a twelve month high of $19.90. The stock has a market cap of $1.38 billion, a price-to-earnings ratio of 10.10, a price-to-earnings-growth ratio of 0.66 and a beta of 0.52. The company has a current ratio of 2.20, a quick ratio of 0.98 and a debt-to-equity ratio of 0.21. The company has a fifty day moving average price of $14.39 and a 200 day moving average price of $14.74.

Afya (NASDAQ:AFYA) last released its quarterly earnings data on Wednesday, March 11th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.36 by $0.05. Afya had a return on equity of 18.77% and a net margin of 20.31%.The company had revenue of $147.08 million for the quarter, compared to analyst estimates of $174.74 million. Equities research analysts forecast that Afya Limited will post 1.52 earnings per share for the current fiscal year.

Afya Announces Dividend

The business also recently declared an annual dividend, which will be paid on Monday, April 6th. Investors of record on Wednesday, March 25th will be given a dividend of $0.656 per share. The ex-dividend date of this dividend is Wednesday, March 25th. This represents a yield of 433.0%. Afya’s payout ratio is 45.21%.

Analysts Set New Price Targets

Several brokerages have issued reports on AFYA. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $22.00 price objective (down from $24.50) on shares of Afya in a research report on Wednesday, January 7th. Sanford C. Bernstein upgraded shares of Afya to a “market perform” rating in a research note on Friday, January 16th. UBS Group reiterated a “neutral” rating and issued a $16.00 price target (down from $18.00) on shares of Afya in a research note on Friday, January 16th. Bank of America downgraded Afya from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $22.00 to $17.00 in a report on Tuesday, February 24th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Afya in a research report on Wednesday, January 21st. One analyst has rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $17.30.

Institutional Trading of Afya

Hedge funds and other institutional investors have recently bought and sold shares of the company. Goldman Sachs Group Inc. raised its stake in Afya by 167.3% during the first quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company’s stock valued at $809,000 after buying an additional 28,226 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Afya by 85.1% in the 2nd quarter. Geode Capital Management LLC now owns 52,111 shares of the company’s stock worth $931,000 after acquiring an additional 23,961 shares in the last quarter. Quadrature Capital Ltd bought a new stake in shares of Afya in the 2nd quarter valued at approximately $181,000. Quantbot Technologies LP bought a new stake in shares of Afya in the 2nd quarter valued at approximately $117,000. Finally, Arrowstreet Capital Limited Partnership raised its position in shares of Afya by 5.6% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 68,169 shares of the company’s stock valued at $1,217,000 after acquiring an additional 3,626 shares in the last quarter. 88.02% of the stock is owned by institutional investors.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.